期刊文献+

吉西他滨对人子宫颈癌HeLa细胞的放射增敏作用及其机理研究 被引量:4

Mechanistic study of radiosensitization by gemcitabine on human squamous carcinoma cell line of the cervix
原文传递
导出
摘要 目的研究低浓度[即处理24 h时的10%药物致死剂量,24 h IC10]吉西他滨对人宫颈癌HeLa细胞的放射增敏作用及其机理。方法采用四甲基偶氮唑蓝(MTT)法筛选吉西他滨增敏实验的浓度(即24 h IC10);以该浓度吉西他滨处理HeLa细胞4、8、12及24 h,弃药后立刻行60Coγ射线照射(4、6、8 Gy),计数细胞存活分数,计算增敏比;同时采用流式细胞仪分析细胞周期分布和凋亡效应,蛋白印迹杂交法分析p53、bcl-2及box蛋白表达量的变化。结果吉西他滨的24 h IC10,为0.01μmol/L,该浓度吉西他滨分别处理细胞4、8、12及24 h,弃药后立刻照射,增敏比分别为1.19、1.35、1.72、1.93。流式细胞仪分析显示,S期细胞比例随吉西他滨处理时间延长而逐渐升高(P<0.01),其中处理24 h时,S期细胞占51.8%。吉西他滨处理后照射,凋亡细胞比例占21.6%,同时,凋亡相关基因p53、bcl-2及bax蛋白的表达量,与单纯吉西他滨处理及单纯照射相比无明显变化(P>0.05)。结论低浓度吉西他滨对HeLa细胞具有放射增敏作用,其增敏比随吉西他滨处理时间延长而增加。增敏机理与细胞S期阻滞密切相关,而与引发细胞凋亡关系不明显。 Objective To investigate whether gemcitabine ( dFdC ) at the non-cytotoxic concentration enhances the effect of irradiation on human squamous carcinoma cells of the uterine cervix (HeLa) in vitro, and to evaluate the mechanism by which dFdC at the non-cytotoxic concentration[24 h 10% inhibiting concentration ( IC 10 )] is able to enhance radiation-induced cytotoxicity to HeLa in vitro. Methods The non-cytotoxic concentration (24 h IC10 ) of dFdC was determined by methyl thiazolyl tetrazolium(MTT). After exposure to the non-cytotoxic concentration(0. 01 μmol/L) for 4,8,12 and 24 hours followed by immediate irradiation(4,6 and 8 Gy) , the surviving fraction was counted and the radiation enhancement ratio ( RER) was evaluated. Cell cycle distribution and apoptosis were analyzed by flow cytometry. The expressions of p53, bcl-2 and bax were studied by western blot. Results After exposure to non-cytotoxic concentration (0. 01 μmol/L) for4,8,12 and 24 hours followed by immediate irradiation, the RER was 1. 19,1. 35,1. 72 and 1. 93, respectively. After exposed to dFdC, HeLa cells showed an S phase block. The proportion of S phase cells was elevated with the increase of exposure duration (P <0. 01). The S-phase proportion increased to 51. 8% at 24 hours of exposure. Meanwhile, compared with the single-agent treatments, combination of dFdC and radiation did not additionally increase the number of apoptotic cells and expression of proteins related to apoptosis such as p53, bcl-2 and bax ( P > 0. 05). Conclusions HeLa cells were radiosensitive at IC10 concentration of dFdC. The radiosensitization effect depends on the exposure duration to dFdC. There appears a strong association between the radiosensitization and the progression of cells into S-phase after dFdC treatment. Combination of dFdC and radiation did not increase apoptosis of HeLa cells.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2004年第5期342-345,共4页 Chinese Journal of Obstetrics and Gynecology
关键词 吉西他滨 子宫颈癌 HELA细胞 放射增敏作用 HeLa cells Deoxycytidine Radiation tolerance Apoptosis Cell cycle
  • 相关文献

参考文献14

  • 1Mose S, Karapetian M, Juling-Pohlit L, et al. Radiation enhancement of gemcitabine in two human squamous cell carcinoma cell lines. Anticancer Res, 2000, 20(1A):401-405.
  • 2Ostruszka LJ, Shewach DS. The role of cell cycle progression in radiosensitization by 2′,2′-difluoro-2′-deoxycytidine. Cancer Res, 2000,60:6080-6088.
  • 3Stefania P, Franco M, Pamela P, et al. Effects of gemcitabine in normal and transformed human lung cell cultures: cytotoxicity and increase in radiation sensitivity. Tumori,1999,85:503-507.
  • 4Milas L, Fujii T, Hunter N, et al. Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Res, 1999,59:107-114.
  • 5Mason KA, Milas L, Hunter NR, et al. Maximizing therapeutic gain with gemcitabine and fractionated radiation. Int J Radiat Oncol Biol Phys, 1999,44:1125-1135.
  • 6Rieger J, Durka S, Streffer J, et al. Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone. Eur J Pharmacol, 1999,365(2-3):301-308.
  • 7Tolis C, Peters GJ, Ferreira CG, et al. Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines. Eur J Cancer, 1999, 35:796-807.
  • 8Ren Q, Kao V, Grem JL. Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2′-deoxyuridine in HT-29 colon cancer cells. Clin Cancer Res, 1998,4:2811-2818.
  • 9Lawrence TS, Chang E Y, Hahn T M, et al. Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2′,2′-difluoro-2′-deoxycytidine (Gemcitabine).Clin Cancer Res, 1997,3:777-782.
  • 10Mohideen MN, McCall A, Kamradt M, et al. Activity of gemcitabine and its radiosensitization of human cervical cancer cells. Proc Am Soc Clin Oncol,1997,16:865.

二级参考文献2

  • 1N. Androulakis,C. Kouroussis,S. Kakolyris,S. Tzannes,E. Papadakis,C. Papadimitriou,A. Geroyianni,T. Georgopoulou,I. Dimopoulou,J. Souglakos,A. Kotsakis,N. Vardakis,D. Hatzidaki,V. Georgoulias. Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: A multicenter phase II study[J] 1998,Annals of Oncology(10):1127~1130
  • 2管忠震,陈茹琴,徐光川,李宇红,许立功,李龙云,刘叙仪,廖美琳,李金瀚.Gemcitabine治疗晚期非小细胞肺癌的临床研究[J].癌症,1999,18(3):241-245. 被引量:177

共引文献60

同被引文献11

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部